A study presented at Digestive Disease Week 2017 examined the effectiveness of an underwater colonoscopy technique, Medscape reports.
GI & Endoscopy
University of Chicago Medicine created ILColonCARES.org to help providers schedule colorectal cancer screenings for residents aged 50-years-old to 75-years-old.
Synthetic Biologics' C. difficile drug, ribaxamase, achieved its primary endpoint in a phase 2b trial.
A study presented at Digestive Disease Week examined how patient genotyping with advanced cirrhosis from hepatitis C virus could help healthcare professionals predict likelihood of improvement after treatment.
A study presented at Digestive Disease Week examined the effectiveness of non-surgical endoscopic sleeve gastroplasty in individuals struggling with obesity who are not candidates for weight loss surgery.
Advertisement
Check-Cap and GE Healthcare achieved their first development milestone when GE's developed and tested X-rays passed all tests to ensure C-scan system compliance.
Takeda Pharmaceuticals reported underlying revenue growth of 6.9 percent from fiscal year 2015 to fiscal year 2016.
Harrisburg (Pa.) Gastroenterology is notifying patients of a potential data breach exposing 93,323 patient records, Healthcare IT News reports.
A study presented at Digestive Disease Week 2017 examined patient satisfaction with irritable bowel syndrome treatment.
Here are six updates on GI companies from the past week.